Our previously developed Western blot analysis for 14-3-3 proteins is a qualitative assay giving either a positive or a negative reaction and is limited by the sensitivity of the assay itself. A potentially more sensitive test is a quantitative test that has the potential to be more informative in the """"""""preclinical/incubating"""""""" stages of the diseases particularly in animals subclinically infected with transmissible spongiform encephalopathies (TSEs) or in evaluating the pathophysiology of neuronal destruction in a time-course study of both animals and humans infected with TSEs. An ELISA test is being developed for the quantitative analysis of 14-3-3 proteins. Seven different polyclonal antibodies have been developed for analysis in an ELISA test. Standards have been obtained, and a double-sandwich has been developed and is undergoing standardization.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Intramural Research (Z01)
Project #
1Z01NS002962-01
Application #
6163149
Study Section
Special Emphasis Panel (CNSS)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code